Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. WA BioHistory (TM)
Career
Job Search Post a Job Destination WA
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
News
 Industry News
 Submit News Release
 Calendar
 Submit Event
 CEO Reading
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
 
Vaccines.gov: your best shot at good health.
 
Community Service Ad: Every Child Deserves a Chance to Play Baseball
 
Saving Lives. Protecting People. Saving Money Through Prevention.
 
3rd Annual Pre-Filled Syringes Summit, Sept. 24-26 - Washington DC

Industry News

News

Submit News Release


Search Articles: 

  • Novartis wins GBCHealth Business Action on Health award for social ventures initiative  Novartis announced that GBCHealth, a coalition of more than 230 private sector companies working to improve global health, has awarded the company's Arogya Parivar program the Business Action on Health Award for Application of Core Competence.
    May 17, 2013  
  • Canada to improve the yield, sustainability and profitability of Canadian wheat  The Government of Canada, the Government of Saskatchewan and University of Saskatchewan announced the creation of a new Canadian Wheat Alliance. This initiative will coordinate R&D projects to improve the yield of Canadian wheat by reducing losses under extreme weather conditions.
    May 16, 2013  
  • SciClone and Zensun sign licensing agreement for heart failure drug Neucardin(TM) in China  SciClone announced an agreement with Zensun Science & Technology granting SciClone a license and exclusive rights in China, Hong Kong and Macau to promote, market, distribute and sell Neucardin™, a novel, first-in-class therapeutic drug for treatment of patients with intermediate to advanced CHF.
    May 16, 2013  
  • Hyperion Therapeutics added to NASDAQ Biotechnology Index  Hyperion Therapeutics announced that it has been selected for addition to the NASDAQ Biotechnology Index®. The semi-annual re-ranking of the NASDAQ Biotechnology Index will become effective May 20, 2013.
    May 16, 2013  
  • Bristol-Myers Squibb announces intention to voluntarily delist preferred stock   Bristol-Myers Squibb announced that it has notified the New York Stock Exchange of its intention to voluntarily delist its $2 Convertible Preferred Stock from the NYSE. Currently, 5,064 shares of Preferred Stock remain outstanding.
    May 16, 2013  
  • West Nile virus tracking resumes  West Nile virus tracking and monitoring season is underway and an updated online dead bird reporting system is available for state residents to use. Dead birds can be the first sign that West Nile virus is circulating in a community.
    May 16, 2013  
  • University of Alberta cultivating research for better canola  The U of A’s canola breeding program is getting a $3.1-million funding injection over the next five years. Viterra is contributing more than $1.6 million in financing and in-kind contributions, and the Natural Sciences and Engineering Research Council of Canada is providing $1.5 million.
    May 16, 2013  
  • UNMC researcher offers rare glimpse into Parkinson’s disease using neuroimaging technology  A University of Nebraska Medical Center research team has found a way to monitor brain injuries that occur in Parkinson’s disease providing clinicians a rare glimpse into the disease process. The results were published in the Journal Cerebral Cortex.
    May 16, 2013  
  • Quest Diagnostics acquires Concentra's laboratory business  Quest Diagnostics announced it has acquired the toxicology and clinical laboratory business of medical center operator Concentra, a Humana subsidiary. In addition, Quest has entered into a long-term agreement with Concentra to be its primary provider of workplace toxicology and clinical testing.
    May 16, 2013  
  • Bacterin receives compliance notice from NYSE MKT  Bacterin announced that it has received a compliance notice from the NYSE MKT compliance group. The Company will be required to submit a plan by June 13, 2013 to address how it intends to regain compliance.
    May 16, 2013  

(previous 10 articles)    (next 10 articles)

Submit News Release

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2013 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advertising

WashingtonLifeScience.com is owned and published by Info.Resource, Inc.